Long-term data show watch-and-wait is viable for rectal cancer, with most regrowths salvageable despite adverse baseline MRI features. Long-term data presented at the ESMO GI 2026 Congress provide new ...
Pamela Plasket, RN, discusses the evolving role of oncology nurses as lung cancer patients survive longer on advanced therapies like BiTEs. The landscape of thoracic oncology is undergoing a ...
BC, OCN, ONN-CG, an oncology nurse navigator and clinical advocate at Hackensack Meridian Ocean University Medical Center, shared insights from her 50-year career in nursing — 36 of which have been ...
The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant. The FDA approved Azurity’s Aprepitant Injectable ...
The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant. The U.S. Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results